10 results
P
individuals with a history of higher weight
I/C
weight loss, binge eating
O
lower binge eating
P
Bulimia Nervosa
I/C
Pharmacotherapy, Cognitive Behavioural Therapy, Placebo
O
Remission, Binge Frequency, Treatment Response
P
Yu X, Xu R, Zhang Z, Yang Y, Deng F
I/C
extra-short implants (≤ 6 mm), longer implants (≥ 8 mm)
O
bone augmentation
P
non-psychiatric subjects, psychiatric participants, anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), schizophrenia
I/C
intranasal OT (INOT), placebo
O
food intake, craving, anxiety or stress reduction
P
marginalized individuals
I/C
discrimination, non-marginalized individuals
O
eating disorder psychopathology
P
Patients in the postoperative period following bariatric surgery
I/C
Bariatric surgery
O
Eating disorders
P
DT
I/C
PSU, DEB, BPD, transdiagnostic utility
O
association
P
adolescents, adults
I/C
ENDS use, non-ENDS use
O
alcohol use, marijuana use
P
red yeast rice preparations
I/C
RYR preparations, control treatments
O
adverse health outcomes
P
COVID-19 patients
I/C
3-drugs-3-formulas, conventional treatment
O
duration of fever, cough, fatigue, length of hospital stay, time for nucleic acid conversion, aggravation rate, mortality, recovery rate of chest computerized tomography manifestations, total effectiveness